Background: Alopecic and aseptic nodules of the scalp (AANS) is a new entity reported first in Japan as ‘pseudocyst of the scalp’. Only retrospective studies have been published. Objectives: To describe the clinicopathological features of AANS (pseudocyst), to evaluate the response to doxycycline and to compare the results to those obtained from patients with dissecting cellulitis of the scalp (DCS). Methods: Fifteen patients with AANS and 7 with DCS were prospectively included. A puncture and a biopsy were made. Patients were treated with doxycycline (100 mg/day) for 3 months. Results: AANS affects predominantly young (mean age 29.7 years), Caucasian (11/15), male (14/15) patients. The main location of the nodules was the occiput. The associated alopecia was nonscarring. Material from the puncture was aseptic. The histopathology showed a deep granuloma in 7 of 14 patients and a nonspecific inflammation in 7 patients. After 3 months, 8 patients were cured and 3 had a good response. Conclusions: The singular aspect of the nodules, the nonscarring alopecia, the deep inflammatory infiltrate and the efficacy of doxycycline confer specificity to AANS.

Keywords:
Pseudocyst, scalp, Alopecic nodule
1.
Iwata T, Hashimoto T, Niimura M: A Pseudocyst with inflammatory granulation tissue on scalp – pseudocyst of scalp. Jpn J Clin Dermatol 1992;46:9–16.
2.
Tsuruta D, Hayashi A, Kobayashi H, Nakagawa K, Furukawa M, Ishii M: Pseudocyst of the scalp. Dermatology 2005;210:333–335.
3.
Abdennader S, Reygagne P: Alopecic and aseptic nodules of the scalp. Dermatology 2009;218:86.
4.
Tsuruta D: Reply. Dermatology 2009;218:87.
5.
Chevallier J: Abcès non infectieux et alopéciques du cuir chevelu: nouvelle entité? Nouv Dermatol 1998;17:181.
6.
Ross E, Tan E, Shapiro J: Update on primary cicatricial alopecias. J Am Acad Dermatol 2005;53:1–37.
7.
Fujita M, Harada E, Ikegame S, Ye Q, Ouchi H, Inoshima I, Nakanishi Y: Doxycycline attenuated lung injury by its biological effect apart from its antimicrobial function. Pulm Pharmacol Ther 2007;20:669–675.
8.
Ishikawa C, Tsuda T, Konishi H, Nakagawa N, Yamanishi K: Tetracyclines modulate protease-activated receptor 2-mediated proinflammatory reactions in epidermal keratinocytes. Antimicrob Agents Chemother 2009;53:1760–1765.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.